Skip to Main Content

Paper Details

Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
Pediatr Blood Cancer
4
2023
ACCTTIVE, Patients, Soft Tissue Sarcoma, VHR, adriamycin, anthracycline, anthracyclines, carboplatin, cyclophosphamide, etoposide, patients, pediatric, rhabdomyosarcoma, topotecan, vincristine
Author NameAffiliation
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg University
Kristian W PajtlerHeidelberg University Hospital
Kristian W PajtlerHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg University
Kristian W PajtlerHeidelberg University Hospital
Christian P KratzHannover Medical School
Thomas KlingebielUniversity Hospital of Frankfurt
Ewa KoscielniakStuttgart Cancer Center, Jugend- und Frauenmedizin (Olgahospital)
Ewa KoscielniakUniversity Tubingen
  • 1 - 10

Datasets

Release 1.2